Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Androgen Deprivation Therapy And Morbid Obesity: Do They Share Cardiovascular Risk Through Metabolic Syndrome?
Author: Cleffi, S
Neto, AS
Reis, LO
Maia, P
Fonseca, F
Wroclawski, ML
Neves, M
Pompeo, ACL
Del Giglio, A
Faria, EF
Tobias-Machado, M
Abstract: Background: Although the use of androgen deprivation therapy (ADT) has resulted in improved survival in men with advanced prostate cancer, the resulting hypogonadism is associated with profound adverse effects comparable to those found in morbid obesity, being cardiovascular risk among the most lethal. Objectives: Evaluate metabolic syndrome, metabolic abnormalities and cardiovascular risk in patients with prostate cancer under ADT, not under ADT and morbid obese men. Methods: This is a cross-sectional study that involves 79 men presenting prostate cancer, of whom 54 under ADT and 25 not under ADT and 91 morbidly obese patients paired by sex and age. To define metabolic syndrome, we used the International Diabetes Federation (IDF) criteria. Metabolic abnormalities, metabolic markers and Framingham score to predict the ten year coronary heart disease risk were compared among patients under ADT, not under ADT and morbid obese. Results: Patients under ADT presented significantly greater occurrence of diabetes and central obesity and higher levels of total cholesterol and low density lipoprotein (LDL) compared to eugonadal men. The mean cardiovascular risk was significantly higher in patients under ADT (39.97 +/- 12.53% vs. 26.09 +/- 14.80%; p = 0.021). Morbidly obese subjects had increased ten year coronary heart disease risk; comparable to patients under ADT (p = 0.054). Conclusion: This study suggests that patients under ADT show higher prevalence of metabolic abnormalities and cardiovascular risk similar to those found in morbidly obese subjects. It is possible that both processes share cardiovascular risk through metabolic syndrome. (C) 2010 AEU. Published by Elsevier Espana, S.L. All rights reserved.
Subject: Prostate cancer
Metabolic syndrome
Cardiovascular risk
Morbid obesity
Androgen deprivation
Country: Espanha
Editor: Ene Ediciones Sl
Citation: Actas Urologicas Espanolas. Ene Ediciones Sl, v. 35, n. 5, n. 259, n. 265, 2011.
Rights: fechado
Identifier DOI: 10.1016/j.acuro.2011.01.011
Date Issue: 2011
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
WOS000290512200002.pdf270.47 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.